fda warning letter bpc-157 unapproved new drug FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control FDA is moving to restrict

We are not a compounding pharmacy as defined under 503A, nor an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act

Diaz-Aparicio IPI, Sierra-Torre V, Plaza-Zabala A, Rodrguez-Iglesias N, Mrquez-Ropero M, Beccari S, Huguet P, Abiega O, Alberdi E, Matute C, Bernales I, Schulz A, Otrokocsi L, Sperlagh B, Happonen KE, Lemke G, Maletic-Savatic M, Valero J, Sierra A (2020) Microglia actively remodel adult hippocampal neurogenesis through the phagocytosis secretome

Dedeoglu, J

[16] These remain areas of investigation in humans and should not be interpreted as established risks at this stage